Comorbidities among adult patients with psoriasis in Tianjin: a cross-sectional analysis of the Health Database study

• Published in: BMJ open Vol. 14; no. 5; p. e083683
• Main Authors: Zhang, Yiming, Guo, Yali, Zhang, Kaiyue, Fan, Liyun, Ma, Jingyue, Li, Yan, Zhou, Quan, Zhao, Qian, Hou, Shuping, Wang, Huiping
• Format: Journal Article
• Language: English
• Published: England British Medical Journal Publishing Group 21.05.2024; BMJ Publishing Group LTD; BMJ Publishing Group
• Series: Original research
• Subjects: Adult; Adult dermatology; Age; Aged; Arthritis, Psoriatic - epidemiology; Atherosclerosis; Cardiovascular disease; Case-Control Studies; Cerebrovascular disease; China - epidemiology; Comorbidity; Confounding (Statistics); Cross-Sectional Studies; Databases, Factual; Dermatological epidemiology; Dermatology; Epidemiology; Female; Health insurance; Hospitals; Humans; Hypertension; Hyperthyroidism; Infections; Logistic Models; Male; Mental disorders; Metabolic disorders; Middle Aged; Prevalence; Propensity Score; Psoriasis; Psoriasis - epidemiology; Regression analysis; Rheumatoid arthritis; Sensitivity analysis; Thyroid diseases; Variables; China; Tianjin China; Dermatological epidemiology; Psoriasis; Adult dermatology
• DOI: 10.1136/bmjopen-2023-083683
• ISSN: 2044-6055

ObjectivesThis study aims to examine the prevalence of comorbidities in adult patients with psoriasis and compare them with those in control subjects without psoriasis in Tianjin, China.DesignThe study is a cross-sectionalanalysis.ParticipantsThe participants were established by identifying all patients (age ≥18 years) who visited hospitals and clinics in Tianjin between 1 January 2016 and 31 October 2019.SettingThe study group consisted of 20 678 adult patients with psoriasis, and a comparison group was created after 1:1 propensity score matching. Logistic regression analyses were conducted to examine the risk of 22 comorbidities for these two groups.ResultsPatients with psoriasis had a significantly higher prevalence of 11 comorbidities and a lower prevalence of 2 comorbidities within 12 months of follow-up. Our results also showed that the proportion of psoriatic arthritis might account for approximately 2% of all patients with psoriasis. This psoriatic arthritis group had a higher average age and CCI (Charlson Comorbidity Index) index score (2.27 >1.62, p <0.001) than the non-arthritis group.ConclusionsThis study showed that psoriasis in Tianjin is associated with various comorbidities. It also emphasises the importance of clinical treatment in improving therapeutic effects and reducing the burden of psoriasis in China.